Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ((/sup 125/I)-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT

Journal Article · · Life Sci.; (United States)

The in vitro binding properties of the (/sup 125/I) labeled benzamide, (S(-)-N-((1-ethyl-2-pyrrolidinyl)-methyl)-2-hydroxy-3-iodo-6-methoxy-benzamide, IBZM) were determined in bovine and mouse caudate membrane homogenates and by autoradiography of mouse brain slices. (/sup 125/I)-IBZM binding is saturable and reversible with B/sub max/ of 373 +/- 51 fmol/mg protein and a K/sub d/ of 3.1 +/- 0.62 nM and 0.56 nM as calculated by association and dissociation time constants. In competition experiments, K/sub i/ values for the D-2 antagonists YM-09151-2 and spiperone are 4 orders of magnitude lower than the K/sub i/ value for the D-1 antagonist SCH-23390 and S(-)-IBZM is ten-fold more potent than R(+)-IBZM. (/sup 125/I)-IBZM has a low affinity for serotonin S-2 and for alpha receptors. Therefore, it is a highly selective ligand for dopamine D-2 receptors. Autoradiographic images of brain sections incubated with (/sup 125/I)-IBZM show the dopamine D-2 receptors of the striatum, nucleus accumbens and olfactory tubercle with a high ratio of specific to nonspecific binding. Thus, S(-)-IBZM, when labeled with (/sup 125/I), may be useful for in vivo imaging of dopamine D-2 receptors by single photon emission computerized tomography (SPECT).

Research Organization:
National Institute of Mental Health, Bethesda, MD (USA)
OSTI ID:
6938663
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 42:21; ISSN LIFSA
Country of Publication:
United States
Language:
English

Similar Records

In vitro and in vivo evaluation of (/sup 123/I)IBZM: a potential CNS D-2 dopamine receptor imaging agent
Journal Article · Sat Dec 31 23:00:00 EST 1988 · J. Nucl. Med.; (United States) · OSTI ID:6406676

Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- ((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Journal Article · Sun May 01 00:00:00 EDT 1988 · J. Med. Chem.; (United States) · OSTI ID:6970273

Synthesis and characterization of iodobenzamide analogues: Potential D-2 dopamine receptor imaging agents
Journal Article · Sun Dec 31 23:00:00 EST 1989 · Journal of Medicinal Chemistry; (USA) · OSTI ID:7105468